Chapman Financial Group’s AbbVie ABBV Stock Holding History

Chapman Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$977K	Hold	3,882	–	–	0.65%	46
2026 Q1	$844K	Sell	3,882 -134	-3%	-$29.7K	0.6%	50
2025 Q4	$918K	Sell	4,016 -49	-1%	-$11.2K	0.63%	47
2025 Q3	$941K	Buy	4,065 +1,215	+43%	+$247K	0.65%	46
2025 Q2	$529K	Buy	+2,850	New	+$530K	0.45%	64
2024 Q4	$515K	Buy	+2,900	New	+$533K	0.41%	68

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Chapman Financial Group's ABBV Position: Q2 2026 in Review

Chapman Financial Group held its AbbVie (ABBV) position steady in Q2 2026 at 3,882 shares worth $977K. The position accounts for 0.65% of the portfolio, ranked #46.

Chapman Financial Group first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Chapman Financial Group held 3,882 shares of AbbVie worth $977K as of Q2 2026.
Chapman Financial Group left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.65% of Chapman Financial Group's portfolio in Q2 2026, its #46 holding.
Chapman Financial Group first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Chapman Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.